新着情報
-
感染症疫学チーム 「The benefits and risks of maternal RSV vaccination on mortality in South Africa: A modeling study」を発表 22026/1/20
-
感染症疫学チーム 「Non-Vaccine Serotype Replacement and Subdominant Persistence of Vaccine Types in Nepalese Infants Following PCV10 Introduction」を発表 2026/1/8
-
高病原性ウイルス医薬品開発チーム「Identification of claramine and anidulafungin as entry inhibitors of Crimean–Congo hemorrhagic fever virus」を発表 2026/1/8
-
感染症疫学チーム 「Burden of typhoid fever and antimicrobial resistance in India (2023): a modelling study」を発表 2026/1/7
-
高病原性ウイルス医薬品開発チーム「Remdesivir as a potent antiviral against prototype and current epidemic Oropouche virus strains (BeAn19991 and PE-IAM4637)」を発表 2025/12/19
-
感染症疫学チーム 「Spatiotemporal dynamics of chikungunya transmission in Foshan City, China: a modelling analysis」を発表 2025/12/28
-
感染症疫学チーム 「Age-specific chikungunya outbreak response immunisation strategies in Brazil: a modelling study」を発表 2025/12/4
-
高病原性ウイルス医薬品開発チーム「Crimean-Congo hemorrhagic fever virus NSm protein inhibits the type I interferon signaling by binding to STAT2」を発表 2025/11/4
-
感染症疫学チーム 「Infectious Disease Medical Epidemiology Team：Announcement on Continuing to be cautious: Japanese contact patterns during the COVID-19 pandemic and their association with public health recommendations」を発表 2025/9/24
-
感染症疫学チーム 「Stakeholder meeting report: Chikungunya virus – recent outbreaks, vaccine development and the way forward」を発表 2025/9/19